@exumabio.com
We are harnessing the power of the immune system to target some of the most challenging solid tumor malignancies.
📢
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
PNG
Icon
PNG
About
Description
EXUMA Biotech is a pioneering clinical-stage biotechnology company that is revolutionizing the field of oncology treatment. By harnessing the power of the immune system, they are targeting the most challenging solid tumor malignancies. Combining immuno-oncology with global science and big data, EXUMA Biotech is at the forefront of innovation.
Their primary focus lies in discovering and developing cell and gene therapies for both solid and liquid tumors. Through their tumor metabolism regulated (TMR) CAR-T and CAR-TaNK platforms, they have already achieved remarkable on-target responses in certain hematological malignancies. Now, they are taking cellular therapies a step further by building delivery platforms that will allow more patients to access these life-saving treatments.
EXUMA Biotech's commitment to accessibility drives their development of next-generation autologous cell therapy. They are constantly developing best-in-class delivery solutions to address the unmet needs of the cell therapy space. This includes their centralized process and their subcutaneous, chemotherapy-free technology platform.
With a global network spanning from West Palm Beach to Grand Cayman to Shanghai, EXUMA Biotech is dedicated to fighting cancer around the clock. Their commitment to innovation and data-driven research sets them apart and solidifies their position as a leader in the field of oncology treatment
Company Type
Privately Held
Company Size
11-50
Year Founded
2015
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere 👋
All services online